Smoking Cessation and Menstrual Cycle Phase

Recruiting Phase 4 Interventional Study
Nicotine Dependence Tobacco Smoking Smoking Cessation Nicotine Use Disorder Substance Use Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Female
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
1,200 (estimated)
Sponsor
Centre for Addiction and Mental Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Tobacco use is a risk factor for at least 20 types of cancer and remains the leading preventable cause of cancer in Canada. Smoking cessation is an important cancer prevention strategy for the close to 2 million Canadian women who currently smoke. However, findings from controlled trials and real-world clinical settings indicate that women have greater difficulty achieving abstinence following a q…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Must provide informed consent following the CAMH REDCap e-consent framework and procedures; * Stated willingness to comply with all study procedures; * Naturally cycling individuals with regular MCs (defined as length ranging 21 to 35 days over past 6 months); * Daily smoker o…
Contacts

Laurie A Zawertailo, PhD

4165358501

laurie.zawertailo@camh.ca

CONTACT

Tina Kabir, BMSc

4165358501

tina.kabir@camh.ca

CONTACT